Keywords: advent, generic, gabapentin, impacts, neuropathic, pain, market

Advent of generic gabapentin impacts neuropathic pain market

Article | 18 July 2005

Print This

US Neuropathic Pain, a new report which examines the effects of the entry of generic competition on world drug leader ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in